A 2a/1b full-length p7 inter-genotypic chimeric genome of hepatitis C virus is infectious in vitro

Virology

Volumn 360, Issue 1, 2007, Pages 17-26

  Haqshenas, G ^a   Dong, X ^a,b   Ewart, G ^c   Bowden, S ^d   Gowans, E J ^a,b  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c BIOTRON LIMITED   (Australia)

^d VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

Amantadine; Chimeric virus; Hepatitis C virus; JFH1 strain; p7 protein

Indexed keywords

AMANTADINE; GENE PRODUCT; PROTEIN P7; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; GENETIC ANALYSIS; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID BILAYER; NONHUMAN; NUCLEOTIDE SEQUENCE; P7 GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRAL GENETICS; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; VIRUS VIRULENCE;

AMANTADINE; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; CELL LINE, TUMOR; GENOME, VIRAL; HEPACIVIRUS; HIV INFECTIONS; HUMANS; MOLECULAR SEQUENCE DATA; REASSORTANT VIRUSES; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; VIRAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 33847246478     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.10.014     Document Type: Article

References (49)

1. Berg T., Kronenberger B., Hinrichsen H., Gerlach T., Buggisch P., Herrmann E., Spengler U., Goeser T., Nasser S., Wursthorn K., Pape G.R., Hopf U., and Zeuzem S. Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial. Hepatology 37 6 (2003) 1359-1367
2. Blanchard E., Belouzard S., Goueslain L., Wakita T., Dubuisson J., Wychowski C., and Rouillé Y. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J. Virol. 80 14 (2006) 6964-6972
3. Blight K.J., Kolykhalov A.A., and Rice C.M. Efficient initiation of HCV RNA replication in cell culture. Science 290 5498 (2000) 1972-1974
4. Boume N., Veselenak R.L., Pyles R.B., and Yi M.K. Amantadine reduces infectious hepatitis C virus (HCV) focus formation but not replication of RNA from different HCV genotypes in cell-based assays. Global Antiv. J. 1 (2005) 11-15
5. Bukh J., Miller R.H., and Purcell R.H. Genetic heterogeneity of the hepatitis C virus. Princess Takamatsu Symp. 25 (1995) 75-91
6. Carrere-Kremer S., Montpellier-Pala C., Cocquerel L., Wychowski C., Penin F., and Dubuisson J. Subcellular localization and topology of the p7 polypeptide of hepatitis C virus. J. Virol. 76 8 (2002) 3720-3730
7. Deltenre P., Henrion J., Canva V., Dharancy S., Texier F., Louvet A., De Maeght S., Paris J.C., and Mathurin P. Evaluation of amantadine in chronic hepatitis C: a meta-analysis. J. Hepatol. 41 3 (2004) 462-473
8. Duff K.C., and Ashley R.H. The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. Virology 190 1 (1992) 485-489
9. Duff K.C., Gilchrist P.J., Saxena A.M., and Bradshaw J.P. Neutron diffraction reveals the site of amantadine blockade in the influenza A M2 ion channel. Virology 202 1 (1994) 287-293
10. Ewart G.D., Sutherland T., Gage P.W., and Cox G.B. The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J. Virol. 70 10 (1996) 7108-7115
11. Fargion S., Fracanzani A.L., and Valenti L. Treatment choices for people infected with HCV. J. Antimicrob. Chemother. 53 5 (2004) 708-712
12. Fields B.N., Knipe D.M., and Howley P.M. Fields Virology (1996), Lippincott-Raven Publishers, Philadelphia, PA (Eds.)
13. Gonzalez M.E., and Carrasco L. Viroporins. FEBS Lett. 552 1 (2003) 28-34
14. Griffin S.D., Beales L.P., Clarke D.S., Worsfold O., Evans S.D., Jaeger J., Harris M.P., and Rowlands D.J. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, amantadine. FEBS Lett. 535 1-3 (2003) 34-38
15. Griffin S.D., Harvey R., Clarke D.S., Barclay W.S., Harris M., and Rowlands D.J. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria. J. Gen. Virol. 85 2 (2004) 451-461
16. Griffin S., Clarke D., McCormick C., Rowlands D., and Harris M. Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes. J. Virol. 79 24 (2005) 15525-15536
17. Haqshenas, G., Mackenzie, J.M., Dong, X., and Gowans E.J., in press. The HCV p7 protein is localised in the endoplasmic reticulum when it is encoded by a replication competent genome. J. Gen. Virol.
18. Hope R.G., Murphy D.J., and McLauchlan J. The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins. J. Biol. Chem. 277 6 (2002) 4261-4270
19. Huang Y.W., Haqshenas G., Kasorndorkbua C., Halbur P.G., Emerson S.U., and Meng X.J. Capped RNA transcripts of full-length cDNA clones of swine hepatitis E virus are replication competent when transfected into Huh7 cells and infectious when intrahepatically inoculated into pigs. J. Virol. 79 3 (2005) 1552-1558
20. Koutsoudakis G., Kaul A., Steinmann E., Kallis S., Lohmann V., and Pietschmann T. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 80 11 (2006) 5308-5320
21. Lau J.Y., Davis G.L., Prescott L.E., Maertens G., Lindsay K.L., Qian K., Mizokami M., and Simmonds P. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann. Intern. Med. 124 10 (1996) 868-876
22. Lin C., Lindenbach B.D., Pragai B.M., McCourt D.W., and Rice C.M. Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J. Virol. 68 8 (1994) 5063-5073
23. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 5734 (2005) 623-626
24. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., and Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285 5424 (1999) 110-113
25. Mangia A., Leandro G., Helbling B., Renner E.L., Tabone M., Sidoli L., Caronia S., Foster G.R., Zeuzem S., Berg T., Di Marco V., Cino N., and Andriulli A. Combination therapy with amantadine and interferon in naive patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials. J. Hepatol. 40 3 (2004) 478-483
26. Melton J.V., Ewart G.D., Weir R.C., Board P.G., Lee E., and Gage P.W. Alphavirus 6K proteins form ion channels. J. Biol. Chem. 277 49 (2002) 46923-46931
27. Mould J.A., Paterson R.G., Takeda M., Ohigashi Y., Venkataraman P., Lamb R.A., and Pinto L.H. Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes. Dev. Cell 5 1 (2003) 175-184
28. Nauwynck H.J., Duan X., Favoreel H.W., Van Oostveldt P., and Pensaert M.B. Entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages via receptor-mediated endocytosis. J. Gen. Virol. 80 2 (1999) 297-305
29. Owsianka A., Tarr A.W., Juttla V.S., Lavillette D., Bartosch B., Cosset F.L., Ball J.K., and Patel A.H. Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. J. Virol. 79 17 (2005) 11095-11104
30. Patargias G., Zitzmann N., Dwek R., and Fischer W.B. Protein-protein interactions: modeling the hepatitis C virus ion channel p7. J. Med. Chem. 49 2 (2006) 648-655
31. Pavlovic D., Neville D.C., Argaud O., Blumberg B., Dwek R.A., Fischer W.B., and Zitzmann N. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc. Natl. Acad Sci. U.S.A. 100 10 (2003) 6104-6108
32. Pietschmann T., Kaul A., Koutsoudakis G., Shavinskaya A., Kallis S., Steinmann E., Abid K., Negro F., Dreux M., Cosset F.L., and Bartenschlager R. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad Sci. U.S.A. 103 (2006) 7408-7413
33. Piller S.C., Ewart G.D., Premkumar A., Cox G.B., and Gage P.W. Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers. Proc. Natl. Acad Sci. U.S.A. 93 1 (1996) 111-115
34. Pinto L.H., Holsinger L.J., and Lamb R.A. Influenza virus M2 protein has ion channel activity. Cell 69 3 (1992) 517-528
35. Premkumar A., Wilson L., Ewart G.D., and Gage P.W. Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride. FEBS Lett. 557 1-3 (2004) 99-103
36. Premkumar A., Horan C.R., and Gage P.W. Dengue virus M protein C-terminal peptide (DVM-C) forms ion channels. J. Membr. Biol. 204 1 (2005) 33-38
37. Premkumar A., Dong X., Haqshenas G., and Gage P.W. Amantadine inhibits the function of an ion channel encoded by GB virus-B but fails to inhibit virus replication. Antiv. Ther. 11 3 (2006) 289-295
38. Sakai A., Claire M.S., Faulk K., Govindarajan S., Emerson S.U., Purcell R.H., and Bukh J. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc. Natl. Acad Sci. U.S.A. 100 20 (2003) 11646-11651
39. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed (1989)
40. Steinmann E., Koutsoudakis G., Kallis S., Zitzmann N., Saint N., Penin F., Pieschmann T., and Bartenschlager R. Analysis of amantadine and iminosugar derivates as potential inhibitors of the HCV life cycle. Abstract P-292. 12th International Symposium on HCV and Related Viruses. Montreal, Canada (2005)
41. Sunstrom N.A., Premkumar L.S., Premkumar A., Ewart G., Cox G.B., and Gage P.W. Ion channels formed by NB, an influenza B virus protein. J. Membr. Biol. 150 2 (1996) 127-132
42. Thuluvath P.J., Maheshwari A., Mehdi J., Fairbanks K.D., Wu L.L., Gelrud L.G., Ryan M.J., Anania F.A., Lobis I.F., and Black M. Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naive patients with chronic hepatitis C. Gut 53 1 (2004) 130-135
43. Trowbridge R., and Gowans E.J. Molecular cloning of an Australian isolate of hepatitis C virus. Arch. Virol. 143 3 (1998) 501-511
44. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
45. Wilson L., McKinlay C., Gage P., and Ewart G. SARS coronavirus E protein forms cation-selective ion channels. Virology 330 1 (2004) 322-331
46. Yanagi M., St Claire M., Shapiro M., Emerson S.U., Purcell R.H., and Bukh J. Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology 244 1 (1998) 161-172
47. Yi M., and Lemon S.M. Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells. J. Virol. 78 15 (2004) 7904-7915
48. Yi M., Villanueva R.A., Thomas D.L., Wakita T., and Lemon S.M. From the cover: production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc. Natl. Acad Sci. U.S.A. 103 7 (2006) 2310-2315
49. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad Sci. U.S.A. 102 (2005) 9294-9299